4 Results for "

mixed hyperlipidemia

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "mixed hyperlipidemia" in MCE Product Catalog:

Cat. No.: HY-164740
CAS No.: 2379776-40-4
Synonyms: ARO-APOC3
Plozasiran (ARO-APOC3) is a siRNA targeting APOC3. Plozasiran mediates RNA interference-mediated degradation and silencing of APOC3 mRNA, reducing APOC3 synthesis and expression, apoC3 protein expression, and plasma ApoC3 concentrations. Plozasiran reduces fasting and non-fasting plasma triglyceride concentrations in diet-induced hypertriglyceridemia. Plozasiran can be used in research on hypertriglyceridemia, mixed hyperlipidemia, and mixed dyslipidemia .
loading...
    loading...
Cat. No.: HY-164740A
CAS No.: 2379776-41-5
Synonyms: ARO-APOC3 sodium
Plozasiran sodium (ARO-APOC3 sodium) is a siRNA targeting APOC3. Plozasiran sodium mediates RNA interference-mediated degradation and silencing of APOC3 mRNA, reducing APOC3 synthesis and expression, apoC3 protein expression, and plasma ApoC3 concentrations. Plozasiran sodium reduces fasting and non-fasting plasma triglyceride concentrations in diet-induced hypertriglyceridemia. Plozasiran sodium can be used in research on hypertriglyceridemia, mixed hyperlipidemia, and mixed dyslipidemia .
loading...
    loading...
Cat. No.: HY-139134
CAS No.: 155730-92-0
S-2E is an orally active and noncompetitive HMG-CoA reductase and acetyl-CoA carboxylase inhibitor. S-2E has an anti-hyperlipidemic action. S-2E has the potential for familial hypercholesterolemia and mixed hyperlipidemia research .
loading...
    loading...
Cat. No.: HY-182257
CAS No.: 609843-23-4
Research Areas:  

Metabolic Disease

Atorvastatin lysine is an inhibitor of HMG-CoA reductase. Atorvastatin lysine can be used to study hypercholesterolemia and mixed hyperlipidemia .
loading...
    loading...